Investigative Ophthalmology & Visual Science, Vol 37, 2165-2176, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells

H Takagi, GL King, GS Robinson, N Ferrara and LP Aiello
Research Division, Harvard Medical School, Boston, Massachusetts, USA.

PURPOSE: To determine the mechanistic role for adenosine and adenosine receptors in the hypoxic induction of vascular endothelial growth factor (VEGF) in retinal microvascular cells. METHODS: Bovine retinal capillary endothelial cells and microvascular pericytes were studied under normoxic (95% air, 5% CO2) or hypoxic conditions (0% to 2% O2, 5% CO2, 93% to 95% N2) using a variety of well-characterized adenosine and adenosine receptor agonists and antagonists. Vascular endothelial growth factor mRNA expression was evaluated by Northern blot analysis, VEGF protein levels were determined by Western blot analysis, and cyclic adenosine monophosphate (cAMP) accumulation was measured by radioimmunoassay. RESULTS: Inhibitors of oxidative respiration increased VEGF mRNA 5 +/- 3 times (P < 0.001) after 3 hours. Adenosine A1 receptor (A1R) agonist N6-cyclopentyl-adenosine did not increase VEGF mRNA at A1R stimulatory concentrations; however, adenosine A2 receptor (A2R) agonists DPMA, NECA, and CGS21680 increased VEGF mRNA in a dose-dependent manner with elevations of 2 +/- 0.3 (P < 0.001), 2.3 +/- 0.5 (P = 0.016), and 2 +/- 0.2 (P = 0.002) times, respectively. A2R antagonist CSC and adenosine degradation by adenosine deaminase reduced hypoxic stimulation of VEGF mRNA 68% +/- 18% (P = 0.038) and 37% +/- 6% (P = 0.025), respectively, in a dose-dependent manner. A1R antagonists DPCPX and 8-PT had no significant effect. Hypoxia and NECA increased VEGF protein secretion 4.7 times, whereas CSC inhibited hypoxia-induced VEGF protein secretion by 96%. NECA and CGS21680 increased cAMP production within 10 minutes, and cAMP stimulation increased VEGF mRNA 4.8 +/- 2.6 times (P = 0.034). CSC suppressed the hypoxic elevation of cAMP (P < 0.05). Inhibition of protein kinase A using H-89 reduced hypoxia-induced VEGF expression 61% +/- 6.3% (P = 0.043) in a dose- dependent manner. CONCLUSIONS: These data suggest that the hypoxia- induced accumulation of adenosine stimulates VEGF gene expression through stimulation of adenosine A2a receptor and subsequent activation of the cAMP-dependent protein kinase A pathway in retinal vascular cells.

This article has been cited by other articles:

				A. N. Clark, R. Youkey, X. Liu, L. Jia, R. Blatt, Y.-J. Day, G. W. Sullivan, J. Linden, and A. L. Tucker A1 Adenosine Receptor Activation Promotes Angiogenesis and Release of VEGF From Monocytes Circ. Res., November 26, 2007; 101(11): 1130 - 1138. [Abstract] [Full Text] [PDF]

				T. H. Adair Growth regulation of the vascular system: an emerging role for adenosine Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R283 - R296. [Abstract] [Full Text] [PDF]

				C. Cristina, G. Diaz-Torga, A. Baldi, A. Gongora, M. Rubinstein, M. J. Low, and D. Becu-Villalobos Increased Pituitary Vascular Endothelial Growth Factor-A in Dopaminergic D2 Receptor Knockout Female Mice Endocrinology, July 1, 2005; 146(7): 2952 - 2962. [Abstract] [Full Text] [PDF]

				E. Suganami, H. Takagi, H. Ohashi, K. Suzuma, I. Suzuma, H. Oh, D. Watanabe, T. Ojima, T. Suganami, Y. Fujio, et al. Leptin Stimulates Ischemia-Induced Retinal Neovascularization: Possible Role of Vascular Endothelial Growth Factor Expressed in Retinal Endothelial Cells Diabetes, September 1, 2004; 53(9): 2443 - 2448. [Abstract] [Full Text] [PDF]

				M. C. Montesinos, J. P. Shaw, H. Yee, P. Shamamian, and B. N. Cronstein Adenosine A2A Receptor Activation Promotes Wound Neovascularization by Stimulating Angiogenesis and Vasculogenesis Am. J. Pathol., June 1, 2004; 164(6): 1887 - 1892. [Abstract] [Full Text] [PDF]

				H. Schwarzenbach, G. Chakrabarti, H. J. Paust, and A. K. Mukhopadhyay Gonadotropin-Mediated Regulation of the Murine VEGF Expression in MA-10 Leydig Cells J Androl, January 1, 2004; 25(1): 128 - 139. [Abstract] [Full Text] [PDF]

				R. J. K. Anand, H.-J. Paust, K. Altenpohl, and A. K. Mukhopadhyay Regulation of Vascular Endothelial Growth Factor Production by Leydig Cells In Vitro: The Role of Protein Kinase A and Mitogen-Activated Protein Kinase Cascade Biol Reprod, May 1, 2003; 68(5): 1663 - 1673. [Abstract] [Full Text] [PDF]

				M. C. Montesinos, A. Desai, J.-F. Chen, H. Yee, M. A. Schwarzschild, J. S. Fink, and B. N. Cronstein Adenosine Promotes Wound Healing and Mediates Angiogenesis in Response to Tissue Injury Via Occupancy of A2A Receptors Am. J. Pathol., June 1, 2002; 160(6): 2009 - 2018. [Abstract] [Full Text] [PDF]

				I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation Circ. Res., March 22, 2002; 90(5): 531 - 538. [Abstract] [Full Text] [PDF]

				G. Burnstock Purinergic Signaling and Vascular Cell Proliferation and Death Arterioscler. Thromb. Vasc. Biol., March 1, 2002; 22(3): 364 - 373. [Abstract] [Full Text] [PDF]

				S. K. Banerjee, H. W. J. Young, J. B. Volmer, and M. R. Blackburn Gene expression profiling in inflammatory airway disease associated with elevated adenosine Am J Physiol Lung Cell Mol Physiol, February 1, 2002; 282(2): L169 - L182. [Abstract] [Full Text] [PDF]

				A. M. Joussen, S. Huang, V. Poulaki, K. Camphausen, W.-D. Beecken, B. Kirchhof, and A. P. Adamis In Vivo Retinal Gene Expression in Early Diabetes Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 3047 - 3057. [Abstract] [Full Text] [PDF]

				I. M. Olfert, E. C. Breen, O. Mathieu-Costello, and P. D. Wagner Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia J Appl Physiol, September 1, 2001; 91(3): 1176 - 1184. [Abstract] [Full Text] [PDF]

				R Belardinelli, L Belardinelli, and J.C Shryock Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy Eur. Heart J., July 2, 2001; 22(14): 1205 - 1213. [Abstract] [PDF]

				R Tabibiazar and S.G Rockson Angiogenesis and the ischaemic heart Eur. Heart J., June 1, 2001; 22(11): 903 - 918. [PDF]

				I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S. L. Rook, K. Suzuma, E. P. Feener, and L. P. Aiello Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension Diabetes, February 1, 2001; 50(2): 444 - 454. [Abstract] [Full Text]

				C. Robinson and S. Stringer The splice variants of vascular endothelial growth factor (VEGF) and their receptors J. Cell Sci., January 3, 2001; 114(5): 853 - 865. [Abstract] [PDF]

				J.-W. Gu, B. R. Ito, A. Sartin, N. Frascogna, M. Moore, and T. H. Adair Inhibition of adenosine kinase induces expression of VEGF mRNA and protein in myocardial myoblasts Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2116 - H2123. [Abstract] [Full Text] [PDF]

				Y. Hasebe, L. R. Thomson, and C. K. Dorey Pentoxifylline Inhibition of Vasculogenesis in the Neonatal Rat Retina Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2774 - 2778. [Abstract] [Full Text]

				M. E. Olah and F. L. Roudabush Down-Regulation of Vascular Endothelial Growth Factor Expression after A2A Adenosine Receptor Activation in PC12 Pheochromocytoma Cells J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 779 - 787. [Abstract] [Full Text]

				J. M. Fredriksson, J. M. Lindquist, G. E. Bronnikov, and J. Nedergaard Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a beta -Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2 J. Biol. Chem., April 28, 2000; 275(18): 13802 - 13811. [Abstract] [Full Text] [PDF]

				G. McMahon VEGF Receptor Signaling in Tumor Angiogenesis Oncologist, April 1, 2000; 5(90001): 3 - 10. [Abstract] [Full Text]

				M. Clauss and W. Schaper Vascular Endothelial Growth Factor : A Jack-of-All-Trades or a Nonspecific Stress Gene? Circ. Res., February 18, 2000; 86(3): 251 - 252. [Full Text] [PDF]

				G. A. Lutty, C. Merges, and D. S. McLeod 5' Nucleotidase and Adenosine during Retinal Vasculogenesis and Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 218 - 229. [Abstract] [Full Text]

				M. Taomoto, D. S. McLeod, C. Merges, and G. A. Lutty Localization of Adenosine A2a Receptor in Retinal Development and Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2000; 41(1): 230 - 243. [Abstract] [Full Text]

				M. B. Grant, R. W. Tarnuzzer, S. Caballero, M. J. Ozeck, M. I. Davis, P. E. Spoerri, I. Feoktistov, I. Biaggioni, J. C. Shryock, and L. Belardinelli Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial Cells Circ. Res., October 15, 1999; 85(8): 699 - 706. [Abstract] [Full Text] [PDF]

				J.-W. Gu, A. L. Brady, V. Anand, M. C. Moore, W. C. Kelly, and T. H. Adair Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells Am J Physiol Heart Circ Physiol, August 1, 1999; 277(2): H595 - H602. [Abstract] [Full Text] [PDF]

				S. Kobayashi and D. E. Millhorn Stimulation of Expression for the Adenosine A2A Receptor Gene by Hypoxia in PC12 Cells. A POTENTIAL ROLE IN CELL PROTECTION J. Biol. Chem., July 16, 1999; 274(29): 20358 - 20365. [Abstract] [Full Text] [PDF]

				H. Benoit, M. Jordan, H. Wagner, and P. D. Wagner Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression J Appl Physiol, May 1, 1999; 86(5): 1513 - 1518. [Abstract] [Full Text] [PDF]

				K. Suzuma, H. Takagi, A. Otani, H. Oh, and Y. Honda Expression of Thrombospondin-1 in Ischemia-Induced Retinal Neovascularization Am. J. Pathol., February 1, 1999; 154(2): 343 - 354. [Abstract] [Full Text] [PDF]

				Y. Kim, R. Y. Imdad, A. H. Stephenson, R. S. Sprague, and A. J. Lonigro Vascular Endothelial Growth Factor mRNA in Pericytes Is Upregulated by Phorbol Myristate Acetate Hypertension, January 1, 1998; 31(1): 511 - 515. [Abstract] [Full Text] [PDF]

				R. O SCHLINGEMANN and V. W M VAN HINSBERGH Role of vascular permeability factor/vascular endothelial growth factor in eye disease Br. J. Ophthalmol., June 1, 1997; 81(6): 501 - 512. [Full Text] [PDF]

				N. Ferrara and T. Davis-Smyth The Biology of Vascular Endothelial Growth Factor Endocr. Rev., February 1, 1997; 18(1): 4 - 25. [Abstract] [Full Text]

				I. Feoktistov, A. E. Goldstein, S. Ryzhov, D. Zeng, L. Belardinelli, T. Voyno-Yasenetskaya, and I. Biaggioni Differential Expression of Adenosine Receptors in Human Endothelial Cells: Role of A2B Receptors in Angiogenic Factor Regulation Circ. Res., March 22, 2002; 90(5): 531 - 538. [Abstract] [Full Text] [PDF]